Skip to main content
. 2020 Dec 1;9(12):1212. doi: 10.3390/antiox9121212
4-HNE 4-hydroxy-2,3-nonenal
ABVD Adriamycin, Bleomycin, Vincristine and Dexamethasone
ACR Acrolein
AGEs Advanced glycation end-products
ALEs Advanced lipid peroxidation end-products
ALL Acute lymphoblastic leukemia
AML Acute myeloid leukemia
AOPPs Advanced oxidation protein products
APL Acute promyelocytic leukemia
B CLL B-cell chronic lymphoblastic leukemia
BM Bone marrow
CAT Catalase
CHOP Cyclophosphamide, Vincristine, Doxorubicin, and Prednisone
CML Chronic myeloid leukemia
COX Cyclooxygenase
DFX Deferasirox
DLBCL Diffuse large B-cell lymphoma
DNP Dinitrophenylhydrazone
DNPH Dinitrophenylhydrazine
DOX-TRF Doxorubicin-transferrin
ET Essential thrombocythemia
GO Glyoxal
GPX Glutathione peroxidase
HL Hodgkin lymphoma
IOL Iron overload
LO Lipoxygenase
MAD Malondialdehyde
MGO Methyglyoxal
MGUS Monoclonal gammapathy of undetermined significance
MM Multiple myeloma
MPN Myeloproliferative neoplasms
NANA N-acetyl neuraminic acid
NHL Non-Hodgkin lymphoma
NOS Nitric oxide synthase
ns Nonsignificant
ONE 4-oxo-2-nonenal
PC Protein carbonylation
PMF Primary myelofibrosis
PN Protein nitrosylated
PUFA Polyunsaturated fatty acyl
PV Polycythemia vera
ROS Reactive oxygen species
SOD Superoxide dismutase
TBARS Thiobarbituric reactive substances
Trx Thioredoxin
VAD Vincristine–Adriamycin–Dexamethasone